Sun Yat-sen Memorial Hospital
Guangzhou, Guangdong, 510120, China
Location status: Recruiting
NCT Number: NCT06592755
Historically, performing a contralateral thyroid lobectomy and lymph node dissection via the subclavian approach was considered challenging. This study aimed to evaluate the safety and feasibility of single-incision gasless endoscopic total thyroidectomy and central compartment neck dissection via the subclavian approach (SCA) in comparison to conventional open surgery for the treatment of papillary thyroid carcinoma (PTC) retrospectively.
Interested in participating?
Request Info18 year–70 year
All sexes
Observational
Guangzhou, Guangdong, 510120, China
Location status: Recruiting
Historically, performing a contralateral thyroid lobectomy and lymph node dissection via the subclavian approach was considered challenging. This study aimed to evaluate the safety and feasibility of single-incision gasless endoscopic total thyroidectomy and central compartment neck dissection via the subclavian approach (SCA) in comparison to conventional open surgery for the treatment of papillary thyroid carcinoma (PTC) retrospectively.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The included patients chose to undergo single-incision, gasless endoscopic total thyroidectomy with central compartment neck dissection via the subclavian approach based on patients preference.
These patients chose to undergo total thyroidectomy with central compartment neck dissection via conventional open surgery based on patients preference.
Time frame: up to 24 months
The disease-free survival refers to the probability of survival without any biologic, structural, or functional events.
Contact information is provided by the study sponsor or research team.
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Other
Single-Incision Gasless Endoscopic Total Thyroidectomy Via Subclavian Approach Versus Open Surgery for Papillary Thyroid Carcinoma
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07302672
Adenocarcinoma, Adenocarcinoma, Papillary
Beijing, China
View Trial DetailsNCT06623578
Adenocarcinoma, Adenocarcinoma, Papillary
Guangzhou, Guangdong, China
View Trial DetailsNCT05962892
Adenocarcinoma, Adenocarcinoma, Papillary
Beijing, China
View Trial DetailsNCT07521670
Adenocarcinoma, Adenocarcinoma, Papillary
Tokyo, Japan
View Trial Details